1 Haemmerle M, "The platelet lifeline to cancer : challenges and opportunities" 33 : 965-983, 2018
2 Groot Koerkamp B, "Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram" 26 : 1930-1935, 2015
3 Yang P, "Somatic genetic aberrations in gallbladder cancer : comparison between Chinese and US patients" 8 : 604-614, 2019
4 Omar M, "Role of increased mean platelet volume(MPV)and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer" 12 : 922-929, 2018
5 Schweitzer N, "Risk estimation for biliary tract cancer : Development and validation of a prognostic score" 37 : 1852-1860, 2017
6 Bridgewater J, "Prognostic factors for progression-free and overall survival in advanced biliary tract cancer" 27 : 134-140, 2016
7 Li Y, "Prognostic evaluation of colorectal cancer using three new comprehensive indexes related to infection, anemia and coagulation derived from peripheral blood" 11 : 3834-3845, 2020
8 Gu M, "Pretreatment mean platelet volume associates with worse clinicopathologic features and prognosis of patients with invasive breast cancer" 23 : 752-760, 2016
9 Stoiber D, "Platelet-leukocyte interplay in cancer development and progression" 9 : 855-, 2020
10 Cui MM, "Platelet distribution width correlates with prognosis of non-small cell lung cancer" 7 : 3456-, 2017
1 Haemmerle M, "The platelet lifeline to cancer : challenges and opportunities" 33 : 965-983, 2018
2 Groot Koerkamp B, "Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram" 26 : 1930-1935, 2015
3 Yang P, "Somatic genetic aberrations in gallbladder cancer : comparison between Chinese and US patients" 8 : 604-614, 2019
4 Omar M, "Role of increased mean platelet volume(MPV)and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer" 12 : 922-929, 2018
5 Schweitzer N, "Risk estimation for biliary tract cancer : Development and validation of a prognostic score" 37 : 1852-1860, 2017
6 Bridgewater J, "Prognostic factors for progression-free and overall survival in advanced biliary tract cancer" 27 : 134-140, 2016
7 Li Y, "Prognostic evaluation of colorectal cancer using three new comprehensive indexes related to infection, anemia and coagulation derived from peripheral blood" 11 : 3834-3845, 2020
8 Gu M, "Pretreatment mean platelet volume associates with worse clinicopathologic features and prognosis of patients with invasive breast cancer" 23 : 752-760, 2016
9 Stoiber D, "Platelet-leukocyte interplay in cancer development and progression" 9 : 855-, 2020
10 Cui MM, "Platelet distribution width correlates with prognosis of non-small cell lung cancer" 7 : 3456-, 2017
11 Zhang X, "Platelet distribution width correlates with prognosis of gastric cancer" 8 : 20213-20219, 2017
12 Valle JW, "New horizons for precision medicine in biliary tract cancers" 7 : 943-962, 2017
13 McNamara MG, "Neutrophil/lymphocyte ratio as a prognostic factor in biliary tract cancer" 50 : 1581-1589, 2014
14 Leblanc R, "Metastasis : new functional implications of platelets and megakaryocytes" 128 : 24-31, 2016
15 Korniluk A, "Mean platelet volume(MPV) : new perspectives for an old marker in the course and prognosis of inflammatory conditions" 2019 : 9213074-, 2019
16 Jagroop IA, "Mean platelet volume as an indicator of platelet activation : methodological issues" 14 : 335-336, 2003
17 Handtke S, "Large and small platelets: (when) do they differ?" 18 : 1256-1267, 2020
18 Plantureux L, "Impacts of cancer on platelet production, activation and education and mechanisms of cancer-associated thrombosis" 10 : 441-, 2018
19 Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries" 68 : 394-424, 2018
20 Song Q, "Elevated preoperative platelet distribution width predicts poor prognosis in esophageal squamous cell carcinoma" 9 : 15234-, 2019
21 Kondo N, "Elevated perioperative serum CA 19-9 levels are independent predictors of poor survival in patients with resectable cholangiocarcinoma" 110 : 422-429, 2014
22 Macias RI, "Diagnostic and prognostic biomarkers in cholangiocarcinoma" 39 (39): 108-122, 2019
23 Raoof M, "Development and validation of a prognostic score for intrahepatic cholangiocarcinoma" 152 : e170117-, 2017
24 Chen M, "Development and validation of a nomogram for survival benefit of lymphadenectomy in resected gallbladder cancer" 8 : 480-489, 2019
25 Chang J, "Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy : results from mCRC biomarker study" 19 : 15-, 2019
26 Squadroni M, "Cholangiocarcinoma" 116 : 11-31, 2017
27 de Aretxabala X, "Biliary spillage a new prognostic factor in gallbladder cancer?" 8 : 537-538, 2019
28 Jackson SS, "Association between aspirin use and biliary tract cancer survival" 5 : 1802-1804, 2019
29 Zhang K, "A novel scoring system based on hemostatic parameters predicts the prognosis of patients with advanced pancreatic cancer" 19 : 346-351, 2019
30 Yadav S, "A novel clinically based staging system for gallbladder cancer" 18 : 151-159, 2020